NGM BIOPHARMACEUTICALS INC Operating Cash Flow
NGM BIOPHARMACEUTICALS INC reported Operating Cash Flow of -$132.20 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2024-03-11
- NGM BIOPHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2023-12-31 was -$22.96M.
- NGM BIOPHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2023-09-30 was -$27.16M.
- NGM BIOPHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2023-06-30 was -$40.25M.
- NGM BIOPHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2023-03-31 was -$41.83M.
- NGM BIOPHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2023 was -$132.20M.
- NGM BIOPHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2022 was -$144.44M.
- NGM BIOPHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2021 was -$73.23M.
- NGM BIOPHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2020 was -$83.50M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$22.96M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | -$50.13M derived: sum of 2 quarters · filed 2024-03-11 | -$90.38M derived: sum of 3 quarters · filed 2024-03-11 | -$132.20M 10-K · filed 2024-03-11 |
| 2023-09-30 | -$27.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$67.41M derived: sum of 2 quarters · filed 2023-11-02 | -$109.24M 10-Q · filed 2023-11-02 | -$139.64M derived: sum of 4 quarters · filed 2024-03-11 |
| 2023-06-30 | -$40.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$82.08M 10-Q · filed 2023-08-03 | -$112.48M derived: sum of 3 quarters · filed 2024-03-11 | -$140.63M derived: sum of 4 quarters · filed 2024-03-11 |
| 2023-03-31 | -$41.83M 10-Q · filed 2023-05-04 | -$72.23M derived: sum of 2 quarters · filed 2024-03-11 | -$100.38M derived: sum of 3 quarters · filed 2024-03-11 | -$150.53M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-12-31 | -$30.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | -$58.55M derived: sum of 2 quarters · filed 2024-03-11 | -$108.70M derived: sum of 3 quarters · filed 2024-03-11 | -$144.44M 10-K · filed 2024-03-11 |
| 2022-09-30 | -$28.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$78.30M derived: sum of 2 quarters · filed 2023-11-02 | -$114.03M 10-Q · filed 2023-11-02 | -$132.37M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-06-30 | -$50.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$85.89M 10-Q · filed 2023-08-03 | -$104.22M derived: sum of 3 quarters · filed 2024-03-11 | -$113.58M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-03-31 | -$35.74M 10-Q · filed 2023-05-04 | -$54.07M derived: sum of 2 quarters · filed 2024-03-11 | -$63.43M derived: sum of 3 quarters · filed 2024-03-11 | -$86.74M derived: sum of 4 quarters · filed 2024-03-11 |
| 2021-12-31 | -$18.34M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | -$27.69M derived: sum of 2 quarters · filed 2024-03-11 | -$51.00M derived: sum of 3 quarters · filed 2024-03-11 | -$73.23M 10-K · filed 2024-03-11 |
| 2021-09-30 | -$9.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$32.67M derived: sum of 2 quarters · filed 2022-11-03 | -$54.89M 10-Q · filed 2022-11-03 | -$74.93M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$23.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$45.53M 10-Q · filed 2022-08-04 | -$65.58M derived: sum of 3 quarters · filed 2023-02-28 | -$90.74M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$22.23M 10-Q · filed 2022-05-05 | -$42.27M derived: sum of 2 quarters · filed 2023-02-28 | -$67.43M derived: sum of 3 quarters · filed 2023-02-28 | -$86.61M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$20.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$45.20M derived: sum of 2 quarters · filed 2023-02-28 | -$64.39M derived: sum of 3 quarters · filed 2023-02-28 | -$83.50M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$25.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$44.35M derived: sum of 2 quarters · filed 2021-11-04 | -$63.46M 10-Q · filed 2021-11-04 | -$78.06M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$19.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$38.29M 10-Q · filed 2021-08-05 | -$52.89M derived: sum of 3 quarters · filed 2022-03-01 | -$59.59M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$19.11M 10-Q · filed 2021-05-06 | -$33.71M derived: sum of 2 quarters · filed 2022-03-01 | -$40.41M derived: sum of 3 quarters · filed 2022-03-01 | -$48.18M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$14.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$21.30M derived: sum of 2 quarters · filed 2022-03-01 | -$29.07M derived: sum of 3 quarters · filed 2022-03-01 | -$41.17M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$6.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$14.47M derived: sum of 2 quarters · filed 2020-11-12 | -$26.57M 10-Q · filed 2020-11-12 | -$19.57M derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-06-30 | -$7.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$19.88M 10-Q · filed 2020-08-12 | -$12.87M derived: sum of 3 quarters · filed 2021-03-15 | -$18.72M derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-03-31 | -$12.10M 10-Q · filed 2020-05-13 | -$5.09M derived: sum of 2 quarters · filed 2021-03-15 | -$10.94M derived: sum of 3 quarters · filed 2021-03-15 | -$15.23M derived: sum of 4 quarters · filed 2021-03-15 |
| 2018-12-31 | $7.01M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $1.16M derived: sum of 2 quarters · filed 2021-03-15 | -$3.13M derived: sum of 3 quarters · filed 2021-03-15 | -$7.60M 10-K · filed 2021-03-15 |
| 2018-09-30 | -$5.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$10.14M derived: sum of 2 quarters · filed 2019-11-12 | -$14.61M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$4.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$8.75M 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | -$4.46M 10-Q · filed 2019-05-16 | |||
| 2017-12-31 | -$17.41M 10-K · filed 2020-03-17 |